Resource Type

Journal Article 6

Year

2023 1

2022 2

2021 1

2018 1

2015 1

Keywords

Gut microbiota 2

Bifidobacterium longum 1

Lactobacillus plantarum 1

Bile acid (BA) 1

Butyric acid 1

Clinical trial 1

Efficacy 1

Fecal metabolites 1

Hyperlipidemia 1

Inflammatory biomarker 1

Irritable bowel syndrome 1

NSAID 1

Probiotics 1

Rheumatoid arthritis 1

Safety 1

Sinomenine 1

anti-interleukin-5 1

benralizumab 1

child 1

cyclooxygenase 2 inhibitor 1

open ︾

Search scope:

排序: Display mode:

traditional Chinese medicine patterns on patients with pneumoconiosis: a pilot double-blind, randomized, and placebo-controlled

Frontiers of Medicine 2022, Volume 16, Issue 5,   Pages 736-744 doi: 10.1007/s11684-021-0870-5

Abstract: A double-blind, randomized, and placebo-controlled trial was conducted for 24 weeks, in which 96 patientstreatment group was treated with TCM syndrome differentiation, and the control group was treated with placebo

Keywords: pneumoconiosis     randomized controlled trials     traditional Chinese medicine    

Efficacy and safety of benralizumab in patients with eosinophilic asthma: a meta-analysis of randomized placebo-controlled

Ting Liu, Faping Wang, Geng Wang, Hui Mao

Frontiers of Medicine 2018, Volume 12, Issue 3,   Pages 340-349 doi: 10.1007/s11684-017-0565-0

Abstract: Compared with the placebo, benralizumab treatment demonstrated significant improvements in the forced

Keywords: benralizumab     anti-interleukin-5     monoclonal antibody     eosinophilic asthma     meta-analysis    

Efficacy and safety of perioperative parecoxib for acute postoperative pain treatment in children: a meta-analysis

Xueshan Bu,Lei Yang,Yunxia Zuo

Frontiers of Medicine 2015, Volume 9, Issue 4,   Pages 496-507 doi: 10.1007/s11684-015-0414-y

Abstract: to identify randomized controlled trials (RCTs) comparing perioperative parecoxib administration and placeboCompared with children who received placebo treatment, those who received parecoxib demonstrated loweradministration was associated with less acute postoperative pain and fewer adverse events compared with placeboParecoxib administration also resulted in less emergence agitation compared with placebo treatment and

Keywords: NSAID     cyclooxygenase 2 inhibitor     child     pain     postoperative     opioid     placebo    

Alleviates Irritable Bowel Syndrome and Prevents Gut Microbiota Dysbiosis: A Randomized, Double-blind, Placebo-controlled Article

Yang Liu, Xinjie Yu, Leilei Yu, Fengwei Tian, Jianxin Zhao, Hao Zhang, Long Qian, Qun Wang, Zhengqing Xue, Qixiao Zhai, Wei Chen

Engineering 2021, Volume 7, Issue 3,   Pages 376-385 doi: 10.1016/j.eng.2020.06.026

Abstract: The study was a 12-week, randomized, double-blind, placebo-controlled, pilot clinical trial.Seventy-five patients were randomly assigned to receive the placebo, oligosaccharides, or L. plantarum

Keywords: Lactobacillus plantarum     Irritable bowel syndrome     Gut microbiota     Butyric acid     Clinical trial    

Hyperlipidemia by Modulating the Gut Microbiota Composition and Fecal Metabolites: A Randomized, Double-Blind, Placebo-Controlled Article

Chuanqi Chu, Jinchi Jiang, Leilei Yu, Yiwen Li, Songli Zhang, Wei Zhou, Qun Wang, Jianxin Zhao, Qixiao Zhai, Fengwei Tian, Wei Chen

Engineering 2023, Volume 28, Issue 9,   Pages 193-205 doi: 10.1016/j.eng.2023.04.010

Abstract: This study was a six-week, randomized, double-blind, and placebo-controlled pilot clinical trial.Subjects with hyperlipidemia (N = 62) were randomly assigned to receive placebo (N

Keywords: Probiotics     Bifidobacterium longum     Hyperlipidemia     Gut microbiota     Fecal metabolites     Bile acid (BA)    

Decreased Ornithine Level and Alleviation of Rheumatoid Arthritis Patients Assessed by a Randomized, Placebo-Controlled Article

Ying Shi, Hu-Dan Pan, Jian-Lin Wu, Qing-Hua Zou, Xin-Yi Xie, Hong-Gang Li, Hua Zhou, Xi-Qing Bian, Wen-Fei Leng, Can-Jian Wang, Ya-Feng Wang, Yong-Fei Fang, Liang Liu

Engineering 2022, Volume 16, Issue 9,   Pages 93-99 doi: 10.1016/j.eng.2021.04.014

Abstract: In this 24 week, randomized, placebo-controlled, double-blind clinical trial, people with mild to moderate

Keywords: Rheumatoid arthritis     Sinomenine     Efficacy     Safety     Inflammatory biomarker    

Title Author Date Type Operation

traditional Chinese medicine patterns on patients with pneumoconiosis: a pilot double-blind, randomized, and placebo-controlled

Journal Article

Efficacy and safety of benralizumab in patients with eosinophilic asthma: a meta-analysis of randomized placebo-controlled

Ting Liu, Faping Wang, Geng Wang, Hui Mao

Journal Article

Efficacy and safety of perioperative parecoxib for acute postoperative pain treatment in children: a meta-analysis

Xueshan Bu,Lei Yang,Yunxia Zuo

Journal Article

Alleviates Irritable Bowel Syndrome and Prevents Gut Microbiota Dysbiosis: A Randomized, Double-blind, Placebo-controlled

Yang Liu, Xinjie Yu, Leilei Yu, Fengwei Tian, Jianxin Zhao, Hao Zhang, Long Qian, Qun Wang, Zhengqing Xue, Qixiao Zhai, Wei Chen

Journal Article

Hyperlipidemia by Modulating the Gut Microbiota Composition and Fecal Metabolites: A Randomized, Double-Blind, Placebo-Controlled

Chuanqi Chu, Jinchi Jiang, Leilei Yu, Yiwen Li, Songli Zhang, Wei Zhou, Qun Wang, Jianxin Zhao, Qixiao Zhai, Fengwei Tian, Wei Chen

Journal Article

Decreased Ornithine Level and Alleviation of Rheumatoid Arthritis Patients Assessed by a Randomized, Placebo-Controlled

Ying Shi, Hu-Dan Pan, Jian-Lin Wu, Qing-Hua Zou, Xin-Yi Xie, Hong-Gang Li, Hua Zhou, Xi-Qing Bian, Wen-Fei Leng, Can-Jian Wang, Ya-Feng Wang, Yong-Fei Fang, Liang Liu

Journal Article